Tate Michael Truett 4
4 · Astera Labs, Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Astera Labs (ALAB) CFO Tate Truett Receives RSU Award
What Happened Tate Michael Truett, Chief Financial Officer of Astera Labs, was granted 11,787 restricted stock units (RSUs) on February 6, 2026. The award was reported at $0.00 per share (typical for RSU grants) and therefore has no immediate cash purchase price. The RSUs represent a contingent right to receive one share of Astera Labs common stock per RSU upon vesting.
Key Details
- Transaction type: Award/Grant (Code A) — 11,787 RSUs granted on 2026-02-06 at $0.00.
- Vesting: 25% vests on February 15, 2027; remaining RSUs vest in 12 equal quarterly installments thereafter, subject to continued service (footnote F1).
- Ownership disclosure: filing includes a trust disclosure (Tate 1997 Living Trust) and a disclaimer of beneficial ownership to the extent noted (footnote F2).
- Shares owned after the transaction: not specified in the Form 4 filing.
- Filing date: Form 4 filed February 10, 2026, reporting the February 6 grant.
Context RSUs are compensation awards that convert to shares only if and when they vest; they are not an open-market purchase or sale and do not indicate an immediate cash investment or disposition. The trust disclosure notes some shares are held in the Tate 1997 Living Trust and the Reporting Person disclaims beneficial ownership of trust-held securities except for any pecuniary interest.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-06+11,787→ 204,084 total
- 450,281(indirect: By Trust)
Common Stock
[F2]
Footnotes (2)
- [F1]These shares represent an award of restricted stock units ("RSUs") granted on February 6, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.